Table 1. Clinical Characteristics According to the Rhinitis Type.
AR | LAR | NAR | p value* | p value† | |
---|---|---|---|---|---|
Subjects, n (%) | 69 (46.0) | 6 (4.0) | 75 (50.0) | ||
Age (yr) | 28.1±9.5 | 42.3±20.1 | 39.5±15.3 | 0.062 | 0.878 |
Male, n (%) | 34 (49.3) | 3 (50.0) | 33 (44.0) | 1.000 | 1.000 |
Duration (month)‡ | 77.6±95.4 | 106.0±51.2 | 51.1±82.2 | 0.125 | 0.012 |
M-score§ | 14.5±4.4 | 17.7±6.5 | 12.1±7.1 | 0.114 | 0.058 |
Comorbidities, n (%) | |||||
Asthma | 26 (37.7) | 1 (16.7) | 16 (21.3) | 0.410 | 1.000 |
Atopic dermititis | 14 (20.3) | 0 (0) | 1 (1.3) | 0.586 | 1.000 |
Urticaria | 4 (5.8) | 0 (0) | 4 (5.3) | 1.000 | 1.000 |
Drug allergy | 4 (5.8) | 1 (16.7) | 3 (4.0) | 0.349 | 0.269 |
Food allergy | 4 (5.8) | 0 (0) | 3 (4.0) | 1.000 | 1.000 |
Total IgE | 551.3±768.4 | 62.5±75.3 | 73.2±88.2 | 0.004 | 0.914 |
AR, allergic rhinitis; LAR, local allergic rhinitis; NAR, non-allergic rhinitis; IgE, immunoglobulin E.
Continuous variables are expressed as mean±standard deviation.
*Significant difference between LAR and AR, †Significant difference between LAR and NAR, ‡Disease in duration, §Medication score at the first clinic visit.